Thursday, January 31, 2008

Bristol-Myers


Bristol-Myers Squibb lost 89 million dollars in the fourth quarter. The biggest contributing factor? Generic competition for its Plavix drug? A big payout on a patent dispute? Nah. The culprit was subprime. Specifically losses on rotten subprime investments. Pretty incredible considering Bristol-Myers is a pharma company. This has to be subprime contagion at its best or its worst depending on your viewpoint.

For more on this story, check out my segment on BNN by copying and pasting the following link.

http://broadband.bnn.ca/bnn/?id=2223&vid=29124

No comments: